Skip to content
FonteumPublic-records evidence

Desk

Financial distress

Hospital closures, bankruptcies, and debt cycles — the balance-sheet signals that precede a facility going dark.

38 studies on this desk

  • Two federal exclusion lists, and they don't match: the OIG LEIE–SAM.gov overlap

    Only 47.9% of NPI-identified providers under an active federal exclusion — 3,747 of 7,827 — appear on both U.S. federal exclusion lists, the HHS-OIG LEIE and GSA SAM.gov. A SAM.gov-only screen misses 3,133 actively OIG-excluded providers, 45.5% of the LEIE. OIG LEIE release 2026-05-08; SAM.gov as of 2026-06-19.

    2026-06-22 · 9 min
  • Barred, but still listed: excluded providers stay active in the provider directory

    Of 6,150 providers barred from federal health programs by the OIG who appear in NPPES — the national provider identity registry — 6,123 (99.6%) are still listed as active. NPPES does not deactivate a National Provider Identifier when its holder is excluded, so the directory most credentialing checks resolve against shows them as ordinary.

    2026-06-20 · 10 min
  • Medicaid Exclusion List Blind Spots: State Bars the Feds Miss

    Of 4,949 providers with an active state Medicaid exclusion across the 13 state programs Fonteum ingests, 3,188 — 64.4% — have no record on the federal OIG LEIE. Adding the SAM.gov debarment list recovers only 191: 2,997 stay invisible to both federal lists. And 198 are barred across two or more states at once.

    2026-06-19 · 10 min
  • Who Owns Hospitals? Every Ownership Change, Tracked (2026)

    Across the 755 hospital ownership-change transactions on CMS's published file, 2016–2025, the ten most active buyers account for just 11.5% of them and 59.9% of all 461 buyers appear exactly once. America's hospitals change hands constantly — but no one is rolling them up.

    2026-06-17 · 9 min
  • Who owns the medical industry: the Open Payments file nobody opens

    CMS's Open Payments ownership file lists 4,591 stakes that 3,965 physicians held in medical companies in 2024, worth $1.34 billion. The median stake is $19,440, but the top 1% of records hold 62.3% of the value: most are token interests in physician groups, and the dollars sit in a handful of device-company stakes.

    2026-06-17 · 9 min
  • The price-transparency enforcement funnel: 11,440 actions, 28 fines

    Since January 2021, CMS has taken 11,440 hospital price-transparency enforcement actions against 4,975 hospitals. Almost none end in a fine: just 28 reached a civil monetary penalty, the only action that carries one. The rest are warnings, corrective-action requests, and — overwhelmingly — hospitals that fixed the problem and closed the case.

    2026-06-16 · 9 min
  • The few drugs that drive most of Medicare's Part D bill, 2023

    Medicare Part D paid $275.9 billion for 3,598 drugs in 2023. The 100 costliest — just 2.8% of the list — account for $176.2 billion, 63.8% of the bill. Ten drugs alone are a quarter of it, and 61.5% of priced drugs cost more per dose than a year earlier.

    2026-06-16 · 10 min
  • Nursing Home Fines Are Getting Bigger: A Three-Year Trend

    Across three years of CMS nursing-home enforcement — 13,764 fines totaling $459.3M — the size of the typical penalty more than doubled. The median fine rose from $8,193 in 2023 to $22,315 so far in 2026 — up 21% across the two complete years. The whole distribution shifted up, not a few outliers.

    2026-06-16 · 8 min
  • Private Equity Nursing Homes: Who Owns America's Facilities

    Of the 14,425 U.S. skilled nursing facilities in CMS's PECOS ownership file, only 28.1% are independent — owned by individuals or a single-facility entity. The other 71.9% disclose a multi-facility organization among their owners, and 52.3% belong to a group of 10 or more facilities.

    2026-06-16 · 9 min
  • Where nursing-home penalties concentrate: a repeat-citation story, 2026

    Between May 2023 and April 2026, CMS imposed $459.3M in civil money penalties and 2,513 payment denials on 6,884 nursing facilities. Enforcement concentrates: the 53.7% of penalized facilities cited more than once carry 80.1% of the fine dollars and 90.6% of the payment denials — the half cited once drew a fifth of the money.

    2026-06-16 · 9 min
  • Corporate Integrity Agreement Tracker: Who Is Under One (2026)

    Half of America's active federal health-care integrity agreements — 50.0% — sit in just five states. Of the 335 agreements in HHS-OIG's published registry, 114 are currently in effect, and California and Florida alone hold 35 of those active cases, 30.7% of the national total; the remaining 79 are spread across 27 other jurisdictions.

    2026-06-16 · 8 min
  • The $8.5 billion nobody counts: research is most of industry's money

    Every Open Payments study reads the same $3.31 billion general slice. But the largest kind of industry payment is research: $8.49 billion in 2024, 71% of all industry money on just 4.7% of records. And 98.9% of it goes to institutions, not individual physicians — paid out by a field one-third as broad.

    2026-06-16 · 9 min
  • OIG Exclusion Check: The 2026 Excluded-Provider Landscape

    At the July 14, 2026 audit cutoff, the OIG LEIE, SAM.gov, and 13 state Medicaid programs contained 10,824 NPI-identified providers barred from a public health program — yet the single most complete list, the OIG LEIE, named only 6,880 of them. Screen against that one source and 36.4% of excluded providers come back clean.

    2026-06-15 · 11 min
  • Barred but order-eligible: excluded providers still cleared to order and refer in Medicare

    In the June 15, 2026 study snapshot, 170 of 2,008,019 providers cleared to order and refer in Medicare carried an active exclusion or sanction, matched on NPI. Of those 170, 105 had stood for over a year. The result is a dated screening flag, not a current claim against any person.

    2026-06-15 · 10 min
  • State Medicaid Exclusion Lists vs the Federal LEIE: The Gap

    In the July 14, 2026 production observation, 3,188 of 4,949 NPI-identified providers excluded across 13 state Medicaid programs — 64.4% — carried no record on the federal OIG LEIE. Another 15,487 in-force state exclusion records had no NPI and could not be matched to the federal list by identifier.

    2026-06-15 · 9 min
  • Barred but billable: excluded providers still enrolled in Medicare

    19 providers barred from all federal health programs by the OIG still hold an active Medicare enrollment record in PECOS — out of 6,880 in-force NPI-identified federal exclusions. Most trace to a single refresh cycle's lag, but two have stood for over a year, one excluded since 2015.

    2026-06-14 · 9 min
  • Industry payments to providers on the OIG exclusion list

    In program year 2024, drug and device manufacturers reported $3.84 million in Open Payments to 294 physicians and other providers who now sit on the federal OIG exclusion list, spread across 3,055 separate transfers. A single category — debt forgiveness — accounts for $3.27 million of that total.

    2026-06-14 · 10 min
  • DRG Code List with Medicare Payments and Volumes (2026)

    Across all 540 MS-DRGs in the 2024 Medicare inpatient file, hospitals were paid an average of $15,166 per stay against $92,408 in billed charges — a 6.1× gap. Sepsis (DRG 871) was the highest-volume code at 577,119 discharges; CAR T-cell therapy (DRG 018) the costliest at $434,771 per stay.

    2026-06-14 · 10 min
  • Same DRG, wildly different price: hospital charge variation, 2024

    For the same Medicare DRG, hospitals bill wildly different amounts: across 219 high-volume codes in 2024, the 90th-percentile hospital charged a median of 3.8× what the 10th-percentile hospital charged for the identical stay. For sepsis — the most common code, billed by 2,661 hospitals — the spread is 4.4×.

    2026-06-14 · 10 min
  • Same procedure, different price: Medicare Part B charge variation, 2024

    For the same Medicare Part B procedure, in the same care setting, providers bill wildly different amounts: across 997 high-volume procedure-and-setting groups in 2024, the 90th-percentile provider charged a median 3.6× what the 10th-percentile provider charged for the identical service. For a hip replacement, billed by 8,164 surgeons, the spread reaches 16×.

    2026-06-14 · 10 min
  • The 5% of prescribers behind half of Medicare's drug bill

    In 2024 the top 5% of Medicare Part D prescribers — 56,973 of 1.14 million — accounted for 53.5% of the program's $226.7 billion drug bill, while the bottom half split 0.4%. The top 1% alone drove $53.5 billion. The Gini coefficient across prescribers is 0.841.

    2026-06-14 · 11 min
  • The 1% of doctors who get two-thirds of industry money

    In 2024 the top 1% of physicians — 9,792 of the 979,136 who received any industry money — captured 66% of every general-payment dollar tied to a recipient, $1.74 billion of $2.64 billion. The bottom half split 1.2%. Measured across recipients, the Gini coefficient is 0.927, far above the ~0.41 of US household income.

    2026-06-14 · 11 min
  • GLP-1 makers paid 120,237 Medicare prescribers $32.8 million in 2024 — and the prescribers they paid wrote far more

    In 2024, the makers of Ozempic and Mounjaro paid $32.8 million to 120,237 Medicare prescribers for meals, talks, and travel tied to GLP-1 drugs. Prescribers who accepted a payment wrote 78% more GLP-1 prescriptions than those who did not — a correlation this study reports at the group level, without inferring cause.

    2026-06-12 · 12 min
  • The Most Expensive Prescription Drugs in Medicare Part D

    Eliquis cost Medicare Part D $19.88 billion in 2024 — the single costliest drug in the program, yet only its 12th most-prescribed. That inversion defines Part D: brand-name drugs are 23.9% of prescriptions but 90.1% of the dollars, while cheap generics carry the volume and almost none of the cost.

    2026-06-12 · 12 min
  • Industry payments to physicians by state: where the money lands

    Industry's $3.31 billion in 2024 general payments to physicians spread across 59 U.S. jurisdictions, but not in proportion to population. California led at $334.5 million, yet Pennsylvania ranked third and Massachusetts fourth on far fewer payments — Massachusetts averaged $1,031 per payment against Texas's $153. Where royalty recipients live, not where patients are, shapes the map.

    2026-06-12 · 10 min
  • Which companies pay U.S. doctors the most? Device makers, not pharma

    In 2024, drug and device companies disclosed $3.31 billion in general payments to U.S. physicians under the Sunshine Act — and the largest payers are device makers, not pharma. BioNTech led at $180.6 million from just 164 royalty payments; the top 25 of 1,763 reporting companies account for 52% of every general-payment dollar.

    2026-06-12 · 11 min
  • Which medical specialties take the most industry money?

    In 2024, U.S. orthopedic surgeons received $381.4 million in general industry payments — more than any other specialty and over three times the second-place field. Counting spine, joint and sports-medicine subspecialties, orthopedics drew $531.8 million, about 16% of the $3.31 billion total. The average orthopedic payment was $1,711; the average internal-medicine payment was $96.

    2026-06-12 · 11 min
  • What pharma actually buys: food, travel, consulting and royalties

    Industry made 15.4 million general payments to U.S. physicians in 2024, worth $3.31 billion — but the two halves barely overlap. Royalties, speaking and consulting are 2.9% of payments yet 63% of the dollars; food and beverage is 91.7% of payments but 12.4% of the money. The average meal was $29; the average royalty, $56,258.

    2026-06-12 · 10 min
  • The Open Payments Database, 2024: $11.96B in Industry Payments

    The Open Payments database — the federal Sunshine Act disclosure file — recorded $11.96B in industry payments to US clinicians and teaching hospitals in 2024, across 16.1M records. The money is extraordinarily concentrated: royalties are 0.1% of records but 25.6% of the dollars, and orthopaedic surgery leads every specialty.

    2026-06-12 · 12 min
  • The Most Prescribed Drugs in Medicare Part D (2024)

    $226.7 billion bought 1.48 billion prescriptions in Medicare Part D in 2024. The most-prescribed drugs are almost all cheap generics, yet 90% of the dollars went to brand-name drugs — the anticoagulant Eliquis alone cost $19.9 billion, and GLP-1 drugs added $24.6 billion more.

    2026-06-12 · 13 min
  • What Hospitals Charge for the Same Procedure (2024)

    Across 4.95M Medicare inpatient stays at 2,906 hospitals in 2024, hospitals billed an average of $92,408 in covered charges but were paid about $18,360 — a roughly 5x gap. For the same procedure, list-price charges vary up to 59x between hospitals. Charge variation by DRG and state, with reproducible CMS methodology.

    2026-06-12 · 12 min
  • Hospital charity care, by the numbers: who actually gives the most free care

    Nonprofit hospitals — tax-exempt in exchange for community benefit — deliver charity care worth just 1.53% of their patient revenue, the lowest share of any ownership type, below for-profit hospitals (3.00%) and less than half the government rate (3.76%), across $27.68 billion in free care in the federal HCRIS cost reports.

    2026-06-11 · 12 min
  • Rural hospital closures, by the numbers: which hospitals are most at risk

    Rural Critical Access Hospitals — the small facilities at the center of the closure crisis — run a 50.4% financial-distress rate, against 39.2% for urban hospitals, across 6,019 Medicare hospitals in the federal HCRIS cost reports. Their average operating margin is −8.93%, and 682 are losing money on patient care.

    2026-06-11 · 13 min
  • For Profit vs Nonprofit Hospitals: Who Owns Them, Who Profits

    Across 6,019 US hospitals in the federal HCRIS cost reports, for-profit facilities are the only ownership class earning a positive average operating margin — +0.19% — while nonprofit hospitals average −4.75% and government hospitals −62.38%. The ranking holds on every measure, but the gap is narrower than the averages suggest.

    2026-06-11 · 12 min
  • The OIG exclusion list, explained: who gets barred from Medicare, and why

    The OIG List of Excluded Individuals and Entities (LEIE) holds 68,055 active exclusions spanning 1977–2026. The most common reason to be barred from Medicare is not fraud — it is losing a state license: §1128(b)(4) license actions are 41% of the list. And only 10.3% of records carry an NPI, so the list is mostly non-clinicians.

    2026-06-11 · 11 min
  • Hospitals at Risk of Closing? The Days-Cash-on-Hand Signal

    Federal HCRIS cost reports let us compute days cash on hand for 5,459 hospitals, but facility-level figures are distorted by system-level cash pooling — so the raw '2,800 hospitals under 30 days' headline is mostly noise. The defensible signal is narrower: 690 hospitals that report thin cash and also run an operating loss.

    2026-06-04 · 14 min
  • Nursing Homes Banned From New Medicare Admissions: The DPNA List

    1,950 US nursing homes have been barred from accepting new Medicare admissions under the Denial of Payment for New Admissions (DPNA) penalty (42 CFR §488.417), across 2,553 separate enforcement actions. A state-by-state breakdown, the longest active bans named from CMS data, and the reproducible SQL behind every figure.

    2026-06-04 · 9 min
  • Hospital Profit Margins: The Gap Between Systems

    Hospital profit margins vary enormously between systems: operating-margin data for 6,000+ U.S. hospitals, computed from CMS HCRIS cost reports (form 2552-10) and benchmarked against the national average. Per-hospital financial-distress flags, a state leaderboard, and the margin gap — published free with a named federal source, methodology, and limitations.

    2026-05-24 · 8 min

Other desks

All research →

What’s on file, by the numbers

Platform snapshot · 2026-08-14

13.4Mproviders & companiesProviders, organizations, owners, and facilities on file
26.2Msource-linked factsSource-linked field facts in the dated platform snapshot
90sources with dataDistinct snapshot source IDs with at least one positive record count
72fresh sourcesDistinct source IDs whose latest positive-data snapshot falls within the preceding 45 days
111sources integratedActive registry rows; integration does not establish a load
13state Medicaid jurisdictionsDistinct states represented in the state-exclusions serving table

Integrated, with-data, and fresh-observation counts are separate. No platform-wide source-completeness count is published. Completeness is source-specific and must be evaluated against the named source's expected scope. State coverage is a separate jurisdiction measure.

Source authority is record-specific

Use the issuer named on the record.

Fonteum spans federal, state, and global public publishers. A source page or returned record identifies its issuer and dataset where that metadata is available. A platform registry count does not assign every page to one authority or establish loaded, fresh, or complete coverage.

Browse source records and their stated limitations →

Reproducible by design

Inspect the evidence each published figure actually supplies.

Source and date

Research pages expose the named public file and observation date where those fields are available. Source-file SHA-256 coverage is separate; facts do not currently link deterministically to signatures.

Available derivation

Studies with a retained release and committed derivation link the SQL or method used. Other studies state the evidence and reproduction limits they actually have.

Daily observations

Dated table row-count observations can detect local drift. They do not imply that an upstream publisher released or Fonteum ingested new data that day.

Named medical review

Reviewed by Jennifer Montecillo, MD, medical reviewer. Non-practicing medical reviewer.

Read the full provenance and attestation methodology →

Request access